SANA RSI Chart
Last 7 days
-20.8%
Last 30 days
-11.6%
Last 90 days
26.3%
Trailing 12 Months
24.3%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | bishop hans edgar | acquired | - | - | 2,774 | - |
Mar 08, 2024 | yang patrick y | sold | -236,300 | 9.452 | -25,000 | - |
Feb 08, 2024 | arch venture fund x, l.p. | bought | 6,000,000 | 5.5 | 1,090,910 | - |
Feb 08, 2024 | nelsen robert | bought | 6,000,000 | 5.5 | 1,090,910 | - |
Feb 08, 2024 | crandell keith | bought | 6,000,000 | 5.5 | 1,090,910 | - |
Jan 05, 2024 | bishop hans edgar | acquired | - | - | 4,901 | - |
Jan 05, 2024 | wilderotter mary agnes | acquired | - | - | 1,470 | - |
Dec 15, 2023 | hordo christian | sold | -300,098 | 4.0013 | -75,000 | evp, chief business officer |
Oct 05, 2023 | wilderotter mary agnes | acquired | - | - | 2,077 | - |
Oct 05, 2023 | bishop hans edgar | acquired | - | - | 6,925 | - |
Which funds bought or sold SANA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | reduced | -41.41 | 525,000 | 1,729,000 | -% |
May 13, 2024 | D.A. DAVIDSON & CO. | new | - | 222,000 | 222,000 | -% |
May 13, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.85 | 278,288 | 472,880 | -% |
May 13, 2024 | Ameritas Investment Partners, Inc. | unchanged | - | 54,855 | 92,660 | -% |
May 13, 2024 | Rafferty Asset Management, LLC | added | 13.33 | 3,173,860 | 4,959,320 | 0.02% |
May 13, 2024 | Nuveen Asset Management, LLC | reduced | -23.82 | 2,575,500 | 5,545,880 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 7.22 | 14,971,700 | 24,168,300 | -% |
May 13, 2024 | Skandinaviska Enskilda Banken AB (publ) | added | 155 | 4,904,650 | 5,834,890 | 0.03% |
May 10, 2024 | Mitsubishi UFJ Trust & Banking Corp | sold off | -100 | -841,541 | - | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | added | 21.02 | 4,084 | 6,160 | -% |
Unveiling Sana Biotechnology, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Sana Biotechnology, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 48.2B | 6.8B | -8.07 | 7.03 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.0B | 2.0B | -57.12 | 9.47 | ||||
BMRN | 15.3B | 2.5B | 74.39 | 6.18 | ||||
INCY | 12.9B | 3.8B | 17.35 | 3.43 | ||||
MID-CAP | ||||||||
BBIO | 5.3B | 107.9M | -9.76 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.51 | 9.96 | ||||
AXSM | 3.6B | 251.0M | -12.12 | 14.31 | ||||
ARWR | 2.7B | 240.7M | -5.82 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.5K | 3.08 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.44 | 4.66 | ||||
NVAX | 1.8B | 996.6M | -4.62 | 1.85 | ||||
CRBP | 458.7M | 881.7K | -13.59 | 481.06 | ||||
INO | 294.6M | 4.9M | -2.36 | 60.54 | ||||
IBIO | 15.6M | 2.1M | -0.67 | 7.61 |
Sana Biotechnology, Inc. News
Balance Sheet | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | 20.5% | 681 | 565 | 631 | 707 | 747 | 823 | 898 | 971 | 1,048 | 1,129 | 1,233 | 1,260 | 1,304 | 730 |
Current Assets | 50.5% | 321 | 214 | 280 | 339 | 370 | 444 | 500 | 494 | 523 | 558 | 613 | 860 | 967 | 384 |
Cash Equivalents | 35.5% | 181 | 134 | 168 | 174 | 160 | 177 | 174 | 205 | 197 | 253 | 442 | 677 | 753 | 127 |
Net PPE | 15.5% | 82.00 | 71.00 | 68.00 | 63.00 | 64.00 | 67.00 | 67.00 | 68.00 | 69.00 | 65.00 | 63.00 | 59.00 | 51.00 | 47.00 |
Goodwill | 0% | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 141 |
Liabilities | 10.2% | 306 | 278 | 266 | 352 | 319 | 323 | 332 | 332 | 346 | 401 | 403 | 354 | 422 | 299 |
Current Liabilities | -18.0% | 53.00 | 64.00 | 67.00 | 112 | 103 | 112 | 115 | 97.00 | 94.00 | 99.00 | 92.00 | 43.00 | 35.00 | 31.00 |
Shareholder's Equity | 30.5% | 375 | 288 | 366 | 355 | 428 | 499 | 566 | 640 | 702 | 729 | 830 | 906 | 882 | - |
Retained Earnings | -11.2% | -1,445 | -1,300 | -1,249 | -1,300 | -1,100 | -1,054 | -974 | -889 | -816 | -785 | -674 | -591 | -610 | -429 |
Additional Paid-In Capital | 12.0% | 1,821 | 1,626 | 1,616 | 1,607 | 1,567 | 1,558 | 1,547 | 1,535 | 1,524 | 1,515 | 1,505 | 1,497 | 1,492 | 8.00 |
Shares Outstanding | 11.8% | 221 | 198 | 197 | 197 | 191 | 191 | 188 | 188 | 186 | 166 | 161 | 180 | - | - |
Float | - | - | - | - | 600 | - | - | - | 1,200 | - | - | - | 3,700 | - | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | -26.3% | -65,632 | -51,959 | -63,550 | -58,801 | -79,272 | -76,067 | -64,796 | -71,478 | -77,709 | -110,099 | -50,486 | -40,556 | -49,913 | -37,559 | -37,510 | -33,366 | -29,547 | - |
Share Based Compensation | 14.6% | 9,092 | 7,931 | 9,003 | 9,848 | 8,751 | 10,591 | 10,080 | 9,911 | 7,755 | 7,313 | 5,950 | 4,941 | 4,158 | 2,791 | 1,166 | 1,116 | 755 | - |
Cashflow From Investing | -604.4% | -77,228 | 15,310 | 51,348 | 42,627 | 62,727 | 88,428 | 31,859 | 77,730 | 12,545 | -73,661 | -185,904 | -35,324 | 49,091 | 13,041 | -268,313 | -36,472 | 39,181 | - |
Cashflow From Financing | 10749.7% | 186,397 | 1,718 | 187 | 29,505 | 236 | 1,061 | 1,621 | 1,579 | 652 | 3,119 | 1,596 | 333 | 626,703 | 103 | 4.00 | 435,578 | 2.00 | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 56,448 | $ 67,166 |
Research and development related success payments and contingent consideration | 38,007 | 120 |
General and administrative | 16,269 | 16,766 |
Total operating expenses | 110,724 | 84,052 |
Loss from operations | (110,724) | (84,052) |
Interest income, net | 3,034 | 1,976 |
Other income (expense), net | 215 | (47) |
Net loss | $ (107,475) | $ (82,123) |
Net loss per common share - basic | $ (0.49) | $ (0.43) |
Net loss per common share - diluted | $ (0.49) | $ (0.43) |
Weighted-average number of common shares - basic | 217,290 | 191,228 |
Weighted-average number of common shares - diluted | 217,290 | 191,228 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 177,054 | $ 133,517 |
Marketable securities | 134,028 | 71,678 |
Restricted cash | 3,832 | 3,832 |
Prepaid expenses and other current assets | 6,349 | 4,488 |
Total current assets | 321,263 | 213,515 |
Property and equipment, net | 81,649 | 70,689 |
Operating lease right-of-use assets | 71,565 | 74,903 |
Intangible asset | 59,195 | 59,195 |
Goodwill | 140,627 | 140,627 |
Other non-current assets | 7,078 | 6,370 |
TOTAL ASSETS | 681,377 | 565,299 |
Current liabilities: | ||
Accounts payable | 6,095 | 4,108 |
Accrued compensation | 13,965 | 23,722 |
Accrued expenses and other current liabilities | 19,674 | 23,462 |
Operating lease liabilities | 13,167 | 13,195 |
Total current liabilities | 52,901 | 64,487 |
Operating lease liabilities, net of current portion | 92,922 | 90,901 |
Contingent consideration, net of current portion | 114,990 | 109,606 |
Success payment liabilities | 45,422 | 12,799 |
Total liabilities | 306,235 | 277,793 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 50,000 shares authorized; zero shares issued and outstanding as of March 31, 2024 and December 31, 2023 | ||
Common stock, $0.0001 par value; 750,000 shares authorized; 221,286 and 197,857 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 22 | 20 |
Additional paid-in capital | 1,820,701 | 1,625,637 |
Accumulated other comprehensive loss | (15) | (60) |
Accumulated deficit | (1,445,566) | (1,338,091) |
Total stockholders' equity | 375,142 | 287,506 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 681,377 | $ 565,299 |